See other companies on Welcome to the Jungle
Journey Clinical
Expanding access to Psychedelic-Assisted Psychotherapy
- 21-100 employees
- Healthcare
- B2C
- B2B
- Mental health
- Wellbeing
- Civic Center, New York, NY
Jump to section
Company mission
To empower licensed mental health professionals to incorporate Ketamine-Assisted Psychotherapy (KAP) in their practice safely and effectively.
Few candidates hear
back within 2 weeks
70% employee growth in 12 months
Our take
With mental health awareness on the rise, the demand for new methods of treatment has increased dramatically. Journey Clinical is meeting this demand by improving access to Psychedelic-Assisted Psychotherapy.
Journey Clinical's main focus is Ketamine Assisted Psychotherapy, which has become increasingly sought after in recent years. KAP has a number of applications, including treatment for anxiety, depression, and PTSD.
Journey Clinical's main challenge will be competing with similar providers, such as Field Trip and Compass Pathways, though its laser focus on KAP should help it stand out. The company has also raised significant funding that will support in scaling its offerings across the US.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Growth opportunities and a high level of freedom
- Health benefits
- Flexible paid time off
- Equity options
- Flexible working hours
- Ketamine-assisted psychotherapy (KAP) prescriber training and mentorship given by leading industry experts
Funding (2 rounds)
Jan 2023
$8.5m
SERIES A
Sep 2021
$3m
SEED
Total funding: $11.5m
This company has top investors
Leadership
Jonathan Sabbagh
(CEO)Was Head of Geneva Office at Columbia Threadneedle Investments. Was Managing Director and Founder of Gottex Brokers SA.
Myriam Barthes
(COO)Previously worked as a Manager at EY, and was an AI Impact Strategist and Client Partner at SparkBeyond.
Office
Articles
Jobs (3)
People, HR, Recruitment
Sales & Account Management